| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.16B | 44.89B | 41.92B | 38.89B | 35.49B | 39.98B |
| Gross Profit | 7.75B | 7.27B | 6.93B | 6.63B | 5.72B | 4.95B |
| EBITDA | 3.66B | 3.51B | 3.36B | 3.15B | 2.57B | 2.01B |
| Net Income | 1.46B | 1.40B | 1.46B | 1.27B | 1.03B | 12.00M |
Balance Sheet | ||||||
| Total Assets | 32.95B | 32.48B | 30.75B | 28.67B | 26.09B | 24.70B |
| Cash, Cash Equivalents and Short-Term Investments | 6.32B | 6.23B | 5.68B | 4.91B | 4.58B | 2.94B |
| Total Debt | 4.42B | 3.06B | 2.79B | 3.98B | 4.52B | 3.70B |
| Total Liabilities | 17.42B | 15.94B | 15.96B | 16.14B | 15.72B | 15.70B |
| Stockholders Equity | 15.52B | 16.53B | 14.79B | 12.53B | 10.36B | 8.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.15B | 2.57B | 1.88B | 1.24B | 580.00M |
| Operating Cash Flow | 0.00 | 2.77B | 3.68B | 2.98B | 2.24B | 1.59B |
| Investing Cash Flow | 0.00 | -1.68B | -1.56B | -1.61B | -291.00M | -438.00M |
| Financing Cash Flow | 0.00 | -1.07B | -1.64B | -1.38B | -272.00M | -2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥69.16B | 33.92 | 3.63% | 2.25% | 9.82% | -50.86% | |
72 Outperform | ¥34.34B | 11.67 | ― | 2.80% | 1.63% | 8.46% | |
67 Neutral | ¥40.73B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥31.13B | 3.47 | 0.31% | 1.75% | -13.34% | -100.75% | |
51 Neutral | ¥65.38B | 9.09 | 2.26% | ― | 5.14% | 32.69% |